THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr non-albicans 4 non-albicans C. glabrata, C. parapsilosis, C. tropicalis, C. krusei 4 C. guil

Similar documents
A A

感染症学雑誌第80巻第6号

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

15,000 例の分析では 蘇生 bundle ならびに全身管理 bundle の順守は, 各々最初の 3 か月と比較し 2 年後には有意に高率となり それに伴い死亡率は 1 年後より有意の減少を認め 2 年通算で 5.4% 減少したことが報告されています このように bundle の merit


2 2 THE JAPANESE JOURNAL OF ANTIBIOTICS 67 1 Feb CRBSI Catheter related bloodstream infection 1. n 167 I. 4 4, % 7 10 Candida albicans

1.8.2 Page MIC () MIC 50 / MIC 90 µg/ml Candida albicans (54) / Candida glabrata (25) 0.25 / 0.5 Candida guilliermondii a) (2)

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr NTT NTT


untitled

38 38 THE JAPANESE JOURNAL OF ANTIBIOTICS 66 1 Feb CT A B A CT B 20xx 2 8 LAM 20xx 1 12 CT S6, S10 Aspergillus spp. Micafungin MCFG 150 mg/ I

CHEMOTHERAPY FEB. 1994


051

日本化学療法学会雑誌第56巻第3号

-95-

Key words: Candida, fungemia, antifungal activity, micafungin, fluconazole-resistant

日本化学療法学会雑誌第54巻第S-1号

untitled

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

原 著 日集中医誌.2010;17:33 ~38. 深在性真菌症の診断 治療における β-d- グルカン値の評価 *1 *1, 2, 5 *3 藤木早紀子志馬伸朗廣瀬有里 *4 *3, 5 小阪直史藤田直久 要約 : 目的 深在性真菌症の診断における β-d- グルカン (BDG) の測定意義と適正

スライド 1

ひとくちメモ/山口英世先生


THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

08-g-”O−}„j‹ê-4.02

Microsoft Word - 01マニュアル・入稿原稿p1-112.doc

日本化学療法学会雑誌第50巻新薬特集号

) Meropenem Chemotherapy (Tokyo) ) panipenem/betamipron Chemotherapy (Tokyo) ) Meropenem Chemotherapy (Toky

Table 1 Laboratory findings on admission

Rinku General Medical Center

CHEMOTHERAPY

THE JAPANESE JOURNAL OF ANTIBIOTICS 66 2 Apr B 2 NTT

051



人事行政の運営状況等の公表(平成19年12月)(PDF)


mogiJugyo_slide_full.dvi

- 1 -

.V...z.\

201604_建築総合_2_架橋ポリ-ポリブテン_cs6.indd

抗菌薬適正使用支援プログラム実践のためのガイダンス

DIC vegetation 1 nonbacterial thrombogenic e

PowerPoint プレゼンテーション

名称未設定-1

THE JAPANESE JOURNAL OF ANTIBIOTICS 68 3 June 2015 Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis % 2 S. pneumon

Japanese Y Y


FLCZ C. albicans BAMPH FLCZ emerging fungal pathogen 31, ARTEMIS DISK Global Antifungal Surveillance Program ARTEMIS Pfaller &

日本化学療法学会雑誌第58巻第2号

Table 1 Epidemiologic characteristics in the elderly patients with sepsis Table 2 Main underlying disease

RX501NC_LTE Mobile Router取説.indb

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

_<74B0><5883><611F><67D3><30DD><30B1><30D7><30ED>_<5FF5><6821>2.pdf

u u u 1 1

13●53頁●6-7▲院内感染対策▲.ppt

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

CHEMOTHERAPY SEPT Amphotericin B (AMPH-B), flucytosine (5- SDA PDA Procedure for disk method 1. Prepare agar plates containing two-fold dilution

F-09C


学校保健304号

学校保健特別増刊号

学校保健290号

untitled

健康文化45

164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10

退職互助だより_cs6.indd

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec DNA 2, , % 1.65% 1.17% 90% 9 Escherichia coli -

Table 1 Profiles of and number of clinical specimens obtain in febrile episodes *

<4D F736F F D2093FA967B88E3905E8BDB8A7789EF E8F5090AB834A F8FC782CC EA197C3834B FC816A2E646F6378>


GJG160842_O.QXD

Table 1 Eight clinical cases with candidemia gra.; granulocytopenia (<400/ml) before candidemia AMoL; acute monocytic leukemia VH; intravenous yperali


Oct THE JAPANESE JOURNAL OF ANTIBIOTICS Pseudomonas aeruginosa 186 P. aeruginosa piperacillin PIPC, taz

THE JAPANESE JOURNAL OF ANTIBIOTICS 67 3 June 2014 STFX mg mg mg mg mg 1

第122号.indd

Cytokine-adsorbing hemofilter:バクスター セプザイリス(AN69ST膜hemofilter)

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination

™ƒ‰ž…j…–†[…X No.49 1.pdf


広報1504月号.indd

敗血症の定義におけるSIRS Criteria.pptx

17 (VAP: Ventilator-associated pneumonia) ICU 6 52 [1] VAP 3 4 Streptococcus pneumonia Haemophilus Influenzae Staphylococcus aureus Pseudomonas

橡200006youbou.PDF

p _ _...c.indd

日本皮膚科学会雑誌第121巻第14号

History I COE

13

菌種 報告年 株数 MIC(μg/mL) Range MIC50 MIC > ( 幾何平均 ) C.tropicalis >

untitled

腎不全-第22回.indd

,788 7,123 5,384 4,915 4,908 4,927 4,895 4,919 4,936 4,927 4,897 5,010 5,008 1,456 1

Table 1. Relationship between date of detection in culture and number of colony of N. asteroides isolated from the patients in various media.

untitled



Transcription:

Apr. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 111 13 B ACTIONs Bundle ACTIONs Bundle 2009 7 ACTIONs Bundle ACTIONs project Appropriate Candidal Treatment, Implementation Of Nonneutropenic strategies ABC A Antifungals B Blood stream infection C Colonization & -Dglucan 2011 ABC Bundle Bundle Bundle Candida albicans non-albicans C. glabrata C. parapsilosis non-albicans

112 14 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr. 2012 non-albicans 4 non-albicans C. glabrata, C. parapsilosis, C. tropicalis, C. krusei 4 C. guilliermondii C. famata C. guilliermondii C. glabrata non-albicans FLCZ non-albicans 4 Candida spp. C. albicans non-albicans C. albicans FLCZ C. albicans 1 non-albicans C. glabrata, C. krusei, C. guilliermondii VRCZ non-albicans 4 C. parapsilosis C. guilliermondii C. famata 2 L- AMB B AMPH-B C. albicans non-albicans Aspergillus AMPH-B C. lusitaniae C. lusitaniae in vitro MIC C. parapsilosis MIC FLCZ MIC 1 g/ml 2 g/ml MIC C. parapsilosis C. glabrata MIC C. glabrata C. glabrata VRCZ 2009 IDSA C. glabrata VRCZ IDSA VRCZ FLCZ

Apr. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 113 15 MIC MIC AMPH-B MIC 50% AMPH-B MIC MIC Bundle Bundle 1 3 ACTIONs project ABC B blood stream infection 1.Bundle Bundle BAL C. albicans non-albicans 4 C. guilliermondii Bundle 2 3

114 16 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr. 2012 2.Bundle 3.Bundle TPN PFALLER, M. A., et al.: Clin. Microbiol. Rev. 20 1 : 133 163, 2007 100% empiric -D- Bundle 2 2 frequently missed detect

Apr. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 115 17 2 2 1 CNS Bacillus 2 2 -D- empiric Bundle empiric empiric empiric presumptive -D- -D- -D- ICU 20 40% 3 4 L-AMB MIC 4. KUHN, D. M., et al.: Antimicrob. Agents Chemother. 46 6 : 1773 1780, 2002

116 18 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr. 2012 L-AMB L-AMB Bundle 2009 7 Earlier appropriate therapy 1 1st F-FLCZ MCFG sepsis L-AMB 1st F-FLCZ MCFG F-FLCZ MCFG L-AMB 1st F-FLCZ MCFG C. glabrata MCFG sepsis septic shock L-AMB sepsis 1,400 sepsis 28 50% sepsis Bundle 1st L-AMB 2 1. Earlier appropriate therapy

Apr. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 117 19 2.Bundle L-AMB AMPH-B MCFG L-AMB 4 non-albicans Acute physiology and chronic health evaluation APACHE 20 sepsis septic shock L-AMB septic shock 3 g/ MRSA L-AMB L-AMB L-AMB septic shock AMPH-B L-AMB L-AMB C. glabrata C. krusei empiric MCFG L-AMB 2nd L-AMB 2nd F-FLCZ 5 MCFG 3 Bundle

118 20 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr. 2012 MCFG 3 3 5 2nd 2nd sepsis C. glabrata C. krusei L-AMB L-AMB F-FLCZ MCFG F-FLCZ VRCZ VRCZ TDM VRCZ VRCZ L-AMB VRCZ 2 Bundle 5 F-FLCZ AMPH-B L-AMB 5-FC nonalbicans Bundle F-FLCZ 5. Bundle Bundle 2 2 Bundle Bundle Yes/No

Apr. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 119 21 6. L-AMB 3. Antifungal heterogeneity L-AMB 6 L-AMB AMPH-B 3 L-AMB MCFG C. parapsilosis Trichosporon Antifungal heterogeneity Antifungal heterogeneity 3 L-AMB AMPH-B Infection control team ICT Bundle 1 Jpn. J. Antibiotics 62 5 : 415 434, 2009 2 ARENDRUP, M. C.: Curr. Opin. Critics Care 16 5 : 445 452, 2010 3 TUMBARELLO, M. et al.: J. Clin. Microbiol. 45 6 : 1843 1850, 2007